Evidence-Generation in Digital Healthcare: Demonstrating Value. Prakash Navaratnam, Sygeny Oy.
-
Upload
finnish-health-startup-association-healthspa -
Category
Healthcare
-
view
81 -
download
0
Transcript of Evidence-Generation in Digital Healthcare: Demonstrating Value. Prakash Navaratnam, Sygeny Oy.
Evidence-Generation in Digital Healthcare: Demonstrating Value
Prakash Navaratnam, PhDSygeny Oy
Helsinki, May 31st, 2016
Value in the context of healthcare
Realized Value: Based on evidence of use of the product in a ‘real world’ setting
Perceived value: Based on product’s characteristics, degree of innovation or uniqueness.
Reference Value:Value of a product or service that is the current standard within the market
Evidence-based Evidence-basedNot Evidence-Based
Value Premium:Difference between Realized and Reference Value
Demonstrating the value premium in healthcare is further complicated by two important factors
Stakeholder Audience
Budget Constraints
Patients, provider, payer, CIO/CTO, regulatory audience, etc. who have different priorities and value perception
Decision-making in healthcare is constrained by costs. If costs outweigh any realized benefit, the product may not be adopted
Measuring value to ensure adoptability and reimbursement
Clinical:
End-points that show reduction or prevention of morbidity and/or mortality.
Economic:
End-points that can show an economic gain in reduced resource use and/or reduced spending.
Humanistic:
End-points that can show an improvement in patient quality of life or patient reported outcomes.
Process:
End-points that are related to the product technical capabilities and the user interaction with
Critical factors to consider prior to value based generation activities
Salience:
-Is there an unmet need the product addresses?
-Is there a rationale that supports the use of this product to address the unmet need?
Perspective:
-Whose perspective do we adopt? -Is it the patient, the payer or society in general?
Metrics:
-Is the data to develop evidence readily available?
-Is it measurable? What is the effort required to develop the evidence needed?
Timing:
-How quickly will the product provide evidence of value?
-What are the both short-term and long-term anticipated gains?
Multiple audiences demand differing evidence that demonstrates value
Evidence of Quality Evidence of Safety
Evidence to Support (Adoption/
Reimbursement)
Evidence of Efficacy (Effectiveness)
Evidence of Value for Money
(Cost-Effectiveness)
The importance of Outcomes Validation
• Why do Outcomes Validation?– Demonstrate Value for Market Access– Regulatory Approval– Competitive Advantage– Investor Acceptance: Demonstrate ROI
• Why Sygeny?– Significant experience in health outcomes research and
evidence generation activities.– Complimentary deep experience in product/service
commercialization, market access and regulatory affairs.– Global Presence: Understand the global healthcare
marketplace.
Unlocking the promise in digital healthPrakash Navaratnam | [email protected]